In other diseases, in particular systemic lupus erythematosus and alcohol‐induced liver disease, GILZ was overexpressed in blood cells of patients under treatment with GC, but no association with the clinical response have been analyzed (38, 39). Here, TSC22D3 is linked to systemic lupus erythematosus.